Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Nasdaq: SHPH · CIK 0001757499 · United States
Every official Shuttle Pharmaceuticals Holdings, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open SHPH filings
Shuttle Pharmaceuticals Holdings, Inc. documents
- Shuttle Pharmaceuticals Holdings, Inc. 10-K 2026SHPH 10-K 2026: annual report for fiscal 2026
- Shuttle Pharmaceuticals Holdings, Inc. 10-K 2025SHPH 10-K 2025: annual report for fiscal 2025
- Shuttle Pharmaceuticals Holdings, Inc. 10-K 2024SHPH 10-K 2024: annual report for fiscal 2024
- Shuttle Pharmaceuticals Holdings, Inc. 10-K 2023SHPH 10-K 2023: annual report for fiscal 2023
- Shuttle Pharmaceuticals Holdings, Inc. 10-K 2022SHPH 10-K 2022: annual report for fiscal 2022
- Shuttle Pharmaceuticals Holdings, Inc. 10-Q 2026SHPH 10-Q 2026: quarterly report for fiscal 2026
- Shuttle Pharmaceuticals Holdings, Inc. 10-Q 2025SHPH 10-Q 2025: quarterly report for fiscal 2025
- Shuttle Pharmaceuticals Holdings, Inc. 10-Q 2024SHPH 10-Q 2024: quarterly report for fiscal 2024
- Shuttle Pharmaceuticals Holdings, Inc. 10-Q 2023SHPH 10-Q 2023: quarterly report for fiscal 2023
- Shuttle Pharmaceuticals Holdings, Inc. 10-Q 2022SHPH 10-Q 2022: quarterly report for fiscal 2022
- Shuttle Pharmaceuticals Holdings, Inc. 8-K 2026SHPH 8-K 2026: current report for fiscal 2026
- Shuttle Pharmaceuticals Holdings, Inc. 8-K 2025SHPH 8-K 2025: current report for fiscal 2025
- Shuttle Pharmaceuticals Holdings, Inc. 8-K 2024SHPH 8-K 2024: current report for fiscal 2024
- Shuttle Pharmaceuticals Holdings, Inc. 8-K 2023SHPH 8-K 2023: current report for fiscal 2023
- Shuttle Pharmaceuticals Holdings, Inc. 8-K 2022SHPH 8-K 2022: current report for fiscal 2022
- Shuttle Pharmaceuticals Holdings, Inc. DEF 14A 2026SHPH DEF 14A 2026: proxy statement for fiscal 2026
- Shuttle Pharmaceuticals Holdings, Inc. DEF 14A 2025SHPH DEF 14A 2025: proxy statement for fiscal 2025
- Shuttle Pharmaceuticals Holdings, Inc. DEF 14A 2024SHPH DEF 14A 2024: proxy statement for fiscal 2024
- Shuttle Pharmaceuticals Holdings, Inc. DEF 14A 2023SHPH DEF 14A 2023: proxy statement for fiscal 2023
- Shuttle Pharmaceuticals Holdings, Inc. DEF 14A 2022SHPH DEF 14A 2022: proxy statement for fiscal 2022
- Shuttle Pharmaceuticals Holdings, Inc. Form 4 2026SHPH Form 4 2026: insider trading filing for fiscal 2026
- Shuttle Pharmaceuticals Holdings, Inc. Form 4 2025SHPH Form 4 2025: insider trading filing for fiscal 2025
- Shuttle Pharmaceuticals Holdings, Inc. Form 4 2024SHPH Form 4 2024: insider trading filing for fiscal 2024
- Shuttle Pharmaceuticals Holdings, Inc. Form 4 2023SHPH Form 4 2023: insider trading filing for fiscal 2023
- Shuttle Pharmaceuticals Holdings, Inc. Form 4 2022SHPH Form 4 2022: insider trading filing for fiscal 2022
- Shuttle Pharmaceuticals Holdings, Inc. S-1 2026SHPH S-1 2026: registration statement for fiscal 2026
- Shuttle Pharmaceuticals Holdings, Inc. S-1 2025SHPH S-1 2025: registration statement for fiscal 2025
- Shuttle Pharmaceuticals Holdings, Inc. S-1 2024SHPH S-1 2024: registration statement for fiscal 2024
- Shuttle Pharmaceuticals Holdings, Inc. S-1 2023SHPH S-1 2023: registration statement for fiscal 2023
- Shuttle Pharmaceuticals Holdings, Inc. S-1 2022SHPH S-1 2022: registration statement for fiscal 2022
- Shuttle Pharmaceuticals Holdings, Inc. 13F 2026SHPH 13F 2026: institutional holdings for fiscal 2026
- Shuttle Pharmaceuticals Holdings, Inc. 13F 2025SHPH 13F 2025: institutional holdings for fiscal 2025
- Shuttle Pharmaceuticals Holdings, Inc. 13F 2024SHPH 13F 2024: institutional holdings for fiscal 2024
- Shuttle Pharmaceuticals Holdings, Inc. 13F 2023SHPH 13F 2023: institutional holdings for fiscal 2023
- Shuttle Pharmaceuticals Holdings, Inc. 13F 2022SHPH 13F 2022: institutional holdings for fiscal 2022
More companies